ATARA BIOTHERAPEUTICS, INC. Cash and Restricted Cash
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Cash and Restricted Cash of $3.22 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-12
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.22M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.36M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.48M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.74M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $3.22M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $8.36M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $8.48M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $5.74M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $16.90M 10-Q · filed 2026-08-12 |
| 2025-03-31 | $13.99M 10-Q · filed 2026-05-12 |
| 2024-12-31 | $25.18M 10-Q · filed 2026-08-12 |
| 2024-09-30 | $46.60M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $31.46M 10-Q · filed 2025-08-11 |
| 2024-03-31 | $35.23M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $25.99M 10-K · filed 2026-03-16 |
| 2023-09-30 | $64.94M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $46.04M 10-Q · filed 2024-08-12 |
| 2023-03-31 | $48.89M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $93.09M 10-K · filed 2025-03-07 |
| 2022-09-30 | $66.46M 10-Q · filed 2023-11-01 |
| 2022-06-30 | $72.03M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $103.02M 10-Q · filed 2023-05-08 |
| 2021-12-31 | $107.48M 10-K · filed 2024-03-28 |
| 2021-09-30 | $114.60M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $125.25M 10-Q · filed 2022-08-08 |
| 2021-03-31 | $152.49M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $201.80M 10-K · filed 2023-02-08 |
| 2020-09-30 | $64.01M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $75.91M 10-Q · filed 2021-08-09 |
| 2020-03-31 | $71.60M 10-Q · filed 2021-05-04 |
| 2019-12-31 | $75.71M 10-K · filed 2023-02-08 |
| 2019-09-30 | $95.83M 10-Q · filed 2020-11-09 |
| 2019-06-30 | $60.55M 10-Q · filed 2020-08-05 |
| 2019-03-31 | $57.56M 10-Q · filed 2020-05-06 |
| 2018-12-31 | $62.09M 10-K · filed 2022-02-28 |
| 2018-09-30 | $67.42M 10-Q · filed 2019-11-07 |
| 2018-06-30 | $104.60M 10-Q · filed 2019-08-08 |
| 2018-03-31 | $91.89M 10-Q · filed 2019-05-09 |
| 2017-12-31 | $80.62M 10-K · filed 2021-03-01 |
| 2017-09-30 | $61.89M 10-Q · filed 2018-11-06 |
| 2017-06-30 | $65.63M 10-Q · filed 2018-08-01 |
| 2017-03-31 | $63.82M 10-Q · filed 2018-05-08 |
| 2016-12-31 | $48.16M 10-K · filed 2020-02-27 |
| 2015-12-31 | $23.94M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |